Related Experiment Video
Updated: Nov 9, 2025

09:25
Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
Published on: October 14, 2016
19.4K
Endometrial Stem/Progenitor cell (ES/PC) Marker Expression Profile in Adenosarcoma and Endometrial Stromal Sarcoma
Ju-Yoon Yoon1, Leanne de Kock2, Colin J R Stewart3
1Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada; Department of Pathology, St. Michael's Hospital, Toronto, ON, Canada.
Cancer Treatment and Research Communications
|April 10, 2021
Summary
Endometrial stem/progenitor cells (ES/PCs) in uterine tumors show prognostic implications. Tumor expression profiles suggest a potential genetic basis for these findings, impacting patient survival.
Area of Science:
- Gynecologic Oncology
- Stem Cell Biology
- Cancer Genomics
Background:
- The uterus relies on endometrial stem/progenitor cells (ES/PCs) for homeostasis.
- ES/PCs reside in the endometrial stroma, the origin of adenosarcoma and endometrial stromal sarcoma (ESS).
- SUZ12 or DICER1 gene alterations in some tumors suggest a link to stem cell biology, but ES/PC involvement is unknown.
Purpose of the Study:
- To investigate the immunophenotypic resemblance of uterine tumors (ESSs and adenosarcomas) to ES/PCs.
- To determine if ES/PC marker expression has prognostic value in these tumors.
- To explore potential genetic drivers, including miRNA profiles in relation to DICER1 mutations.
Main Methods:
- Assessed expression of 11 ES/PC markers and 3 mature stromal proteins in 60 uterine tumors.
- Utilized unsupervised hierarchical clustering for protein expression profiling.
- Analyzed miRNA expression in adenosarcomas with/without DICER1 mutations.
Main Results:
- Tumors showed variable ES/PC marker expression and limited resemblance to ES/PCs.
- ES/PC marker clustering was prognostic for overall and disease-free survival in ESSs.
- DICER1 mutation status correlated with varied miRNA profiles and dysregulated pathways in adenosarcomas.
Conclusions:
- ESSs and adenosarcomas display diverse immunophenotypic similarities to ES/PCs.
- Tumor expression profiles offer prognostic insights.
- These findings may be influenced by underlying genetic alterations.

